Literature DB >> 9396430

Endothelium-dependent dilatation is impaired in young healthy subjects with a family history of premature coronary disease.

P Clarkson1, D S Celermajer, A J Powe, A E Donald, R M Henry, J E Deanfield.   

Abstract

BACKGROUND: A family history of premature coronary artery disease (CAD) in a first-degree relative is an independent risk factor for coronary disease. Both genetic and environmental influences are likely to be responsible and may interact, but their relative importance is unclear. METHODS AND
RESULTS: We studied endothelial function in 50 first-degree relatives (31 men, 19 women; mean age, 25+/-8 years) of patients (men < or = 45 years, women < or = 55 years) with proven CAD. All subjects were well, lifelong nonsmokers, not diabetic, and not hypertensive and took no medications. Using high-resolution external vascular ultrasound, we measured brachial artery diameter at rest and in response to reactive hyperemia (with increased flow causing an endothelium-dependent vasodilatation) and to sublingual glyceryltrinitrate (GTN, an endothelium-independent dilator). Vascular responses were compared with those of 50 healthy control subjects matched for age and sex. Flow-mediated dilatation (FMD) was impaired in the family history group (4.9+/-4.6% versus 8.3+/-3.5% in control subjects, P<.005). In contrast, GTN caused dilatation in all subjects (family history, 17.1+/-8.8%; control subjects, 19.0+/-6.3%; P=NS), suggesting that reduced FMD was due to endothelial dysfunction. When the family history subjects were subdivided, those found to have a serum cholesterol > 4.2 mmol/L (group A, n=10) had mildly impaired FMD compared with control subjects (5.5+/-5.1% versus 8.3+/-3.5%). In others whose affected relative had coronary risk factors (group B, n=24), FMD was also only slightly reduced (6.2+/-4.8% versus 8.3+/-3.5%). In contrast, subjects with no risk factors and whose affected relative had a normal cardiovascular risk factor profile (group C, n=16) had markedly impaired FMD (2.9+/-3.7% versus 8.3+/-3.5%). Although ANOVA of the three family history subgroups did not reach statistical significance (F=2.55, P=.09), pairwise analysis showed that FMD in group C was significantly impaired compared with group B (P=.026).
CONCLUSIONS: Healthy young adults with a family history of premature coronary disease may have impaired endothelium-dependent dilatation, even in the absence of other cardiovascular risk factors. Those subjects, who were free of risk factors and whose affected first-degree relative was free of risk factors, had the most impaired endothelial function, suggesting a genetic influence on early arterial physiology that may be relevant to later clinical disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9396430     DOI: 10.1161/01.cir.96.10.3378

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  32 in total

Review 1.  [Plaque stabilization and endothelial protection by cholesterol synthesis inhibitors].

Authors:  D Müller-Wieland; M Faust; J Kotzka; W Krone
Journal:  Herz       Date:  1999-05       Impact factor: 1.443

Review 2.  Genetic regulation of endothelial function.

Authors:  L C Jones; A D Hingorani
Journal:  Heart       Date:  2005-10       Impact factor: 5.994

3.  Assessing progression or regression of CAD: the role of perfusion imaging.

Authors:  K Lance Gould
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

Review 4.  Monitoring vascular health beyond blood pressure.

Authors:  Daniel A Duprez; Jay N Cohn
Journal:  Curr Hypertens Rep       Date:  2006-08       Impact factor: 5.369

Review 5.  Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

Authors:  Richard J Woodman; Gerard T Chew; Gerald F Watts
Journal:  Drugs       Date:  2005       Impact factor: 9.546

6.  Angiotensin Receptor Expression and Vascular Endothelial Dysfunction in Obstructive Sleep Apnea.

Authors:  Rami N Khayat; Saradhadevi Varadharaj; Kyle Porter; Angela Sow; David Jarjoura; Mikhail A Gavrilin; Jay L Zweier
Journal:  Am J Hypertens       Date:  2018-02-09       Impact factor: 2.689

Review 7.  The L-arginine-nitric oxide pathway in hypertension.

Authors:  Malte Kelm
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

8.  Flow-mediated vasodilatation of the brachial artery in children with chronic kidney disease.

Authors:  Amy C Wilson; Elaine Urbina; Sandra A Witt; Betty J Glascock; Thomas R Kimball; Mark Mitsnefes
Journal:  Pediatr Nephrol       Date:  2008-05-06       Impact factor: 3.714

Review 9.  Nitric oxide insufficiency and atherothrombosis.

Authors:  Barbara Voetsch; Richard C Jin; Joseph Loscalzo
Journal:  Histochem Cell Biol       Date:  2004-08-26       Impact factor: 4.304

10.  Complex trait genetics the role of mechanistic "intermediate phenotypes" and candidate genetic loci.

Authors:  Fangwen Rao; Lian Zhang; Daniel T O'Connor
Journal:  J Am Coll Cardiol       Date:  2008-07-08       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.